The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Post-treatment MRI to predict pathological complete response in triple-negative breast cancer following neoadjuvant chemoimmunotherapy.
 
Toulsie Ramtohul
No Relationships to Disclose
 
Derek Lollivier
No Relationships to Disclose
 
Justine Spriet
No Relationships to Disclose
 
Maxime Jin
No Relationships to Disclose
 
Lounes Djerroudi
No Relationships to Disclose
 
Thomas Gaillard
No Relationships to Disclose
 
Claire Bonneau
No Relationships to Disclose
 
Delphine Loirat
No Relationships to Disclose
 
Diana Bello Roufai
Travel, Accommodations, Expenses - daiichi sankyo; Lilly
 
Youlia Kirova
No Relationships to Disclose
 
Pierre Loap
No Relationships to Disclose
 
Caroline Malhaire
No Relationships to Disclose
 
Anne Vincent-Salomon
Stock and Other Ownership Interests - IBEX Medical Analytics; Primaa
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; IBEX Medical Analytics; IBEX Medical Analytics; IBEX Medical Analytics; Leica biosystems; MSD Oncology; ROCHE
Consulting or Advisory Role - IBEX Medical Analytics; Primaa
Research Funding - AstraZeneca (Inst); IBEX Medical Analytics (Inst); MSD Avenir (Inst); NanoString Technologies (Inst)
Travel, Accommodations, Expenses - NanoString Technologies; Roche/Genentech
Other Relationship - IBEX Medical Analytics
 
Francois Clement Bidard
Consulting or Advisory Role - AstraZeneca; Daiichi-Sankyo; Foresight Diagnostics; Inatherys; Lilly; Menarini Silicon Biosystems; Novartis; Pfizer; Roche; SAGA Diagnostics
Speakers' Bureau - AstraZeneca; Daiichi-Sankyo; Lilly; Novartis; Roche
Research Funding - GE Healthcare (Inst); Menarini Silicon Biosystems (Inst); Merck KGaA (Inst); MSD (Inst); Novartis (Inst); Personalis (Inst); Pfizer (Inst); Prolynx (Inst); Roche (Inst); SAGA Diagnostics (Inst); Tempus (Inst)
Patents, Royalties, Other Intellectual Property - ESR1 & MSI detection techniques (patents) (Inst); Prognosis assessment by a digital pathology assay in early breast cancer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi-Sankyo; Novartis; Pfizer; Roche
 
Anne Tardivon
No Relationships to Disclose
 
Audrey Mailliez
Consulting or Advisory Role - SEAGEN
Travel, Accommodations, Expenses - Lilly; Menarini; MSD Oncology; Novartis
 
Lauren Wallaert
No Relationships to Disclose
 
Luc Ceugnart
No Relationships to Disclose
 
Caroline Nhy
No Relationships to Disclose
 
Luc Cabel
No Relationships to Disclose